Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).
- DOI
- 10.1016/j.breast.2020.06.002
- Published
- 2020 Oct
- Container
- Breast (Edinburgh, Scotland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2020.06.002,
title = {Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).},
author = {Orlando L and Lorusso V and Giotta F and Di Maio M and Schiavone P and Fedele P and Quaranta A and Caliolo C and Ciccarese M and Cinefra M and Romito S and Pisconti S and Prete SD and Aieta M and Rizzi D and Maiello E and Colucci G and Cinieri S},
year = {2020},
journal = {Breast (Edinburgh, Scotland)},
doi = {10.1016/j.breast.2020.06.002},
url = {https://doi.org/10.1016/j.breast.2020.06.002}
}RIS
TY - JOUR TI - Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM). AU - Orlando L AU - Lorusso V AU - Giotta F AU - Di Maio M AU - Schiavone P AU - Fedele P AU - Quaranta A AU - Caliolo C AU - Ciccarese M AU - Cinefra M AU - Romito S AU - Pisconti S AU - Prete SD AU - Aieta M AU - Rizzi D AU - Maiello E AU - Colucci G AU - Cinieri S PY - 2020 JO - Breast (Edinburgh, Scotland) DO - 10.1016/j.breast.2020.06.002 UR - https://doi.org/10.1016/j.breast.2020.06.002 ER -
APA
L, O., V, L., F, G., M, D. M., P, S., P, F., A, Q., C, C., M, C., M, C., S, R., S, P., SD, P., M, A., D, R., E, M., G, C., & S, C. (2020). Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2020.06.002
Source records
- pubmed · retrieved 2026-09-27T00:32:49.028Z